Gilbert J. Burckart

10.0k total citations · 2 hit papers
255 papers, 7.4k citations indexed

About

Gilbert J. Burckart is a scholar working on Pediatrics, Perinatology and Child Health, Transplantation and Surgery. According to data from OpenAlex, Gilbert J. Burckart has authored 255 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Pediatrics, Perinatology and Child Health, 71 papers in Transplantation and 53 papers in Surgery. Recurrent topics in Gilbert J. Burckart's work include Pharmaceutical studies and practices (77 papers), Renal Transplantation Outcomes and Treatments (68 papers) and Pharmacological Effects and Toxicity Studies (41 papers). Gilbert J. Burckart is often cited by papers focused on Pharmaceutical studies and practices (77 papers), Renal Transplantation Outcomes and Treatments (68 papers) and Pharmacological Effects and Toxicity Studies (41 papers). Gilbert J. Burckart collaborates with scholars based in United States, Germany and Switzerland. Gilbert J. Burckart's co-authors include Raman Venkataramanan, Richard J. Ptachcinski, Adriana Zeevi, Jang-ik Lee, Bartley P. Griffith, Thomas E. Starzl, Aldo Iacono, Ashok Jain, James H. Dauber and Sheila Zuckerman and has published in prestigious journals such as New England Journal of Medicine, Nature Reviews Drug Discovery and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Gilbert J. Burckart

244 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Pharmacokinetics of Tacrolimus

1995 655 citations Ashok Jain, Gilbert J. Burckart et al. profile →
Clinical Pharmacokinetics of Cyclosporin

1986 414 citations Gilbert J. Burckart et al. profile →

Peers

Countries citing papers authored by Gilbert J. Burckart

Since Specialization

Citations

This map shows the geographic impact of Gilbert J. Burckart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert J. Burckart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert J. Burckart more than expected).

Fields of papers citing papers by Gilbert J. Burckart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert J. Burckart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert J. Burckart. The network helps show where Gilbert J. Burckart may publish in the future.

Co-authorship network of co-authors of Gilbert J. Burckart

This figure shows the co-authorship network connecting the top 25 collaborators of Gilbert J. Burckart. A scholar is included among the top collaborators of Gilbert J. Burckart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilbert J. Burckart. Gilbert J. Burckart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pediatric Developmental Drug Toxicity: Description of Juvenile Animal Studies in US FDA Prescribing Information and Assessing the Need for New Approach Methodologies 2025 ·The Journal of Clinical Pharmacology ·Gelareh Abulwerdi, Hillary Brenda Nguyen, (unknown), Elizabeth A. Hahn, (unknown), Robert J. Nadeau, Dionna J. Green, Gilbert J. Burckart	1
2	Landscape of regulatory quantitative systems pharmacology submissions to the U.S. Food and Drug Administration: An update report 2024 ·CPT Pharmacometrics & Systems Pharmacology ·Jane P. F. Bai, (unknown), Miao Zhao, Jie Wang, (unknown), (unknown), Justin Earp, Yuching Yang, Jiang Liu, Hao Zhu, Gilbert J. Burckart	7
3	Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products 2024 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), Yow‐Ming Wang, Gilbert J. Burckart, Jayabharathi Vaidyanathan, Shirley K. Seo, Mohamed Ismail Nounou	2
4	Food‐Drug Effects and Pediatric Drug Development Studies Submitted to the US Food and Drug Administration, 2012‐2022 2024 ·The Journal of Clinical Pharmacology ·(unknown), Blessy George, (unknown), (unknown), Vikram Arya, Gelareh Abulwerdi, Gilbert J. Burckart	4
5	Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer Agents 2023 ·The Journal of Clinical Pharmacology ·William C. Zamboni, Rosane Charlab, Gilbert J. Burckart, Clinton F. Stewart	10
6	Obesity Considerations in Pediatric Drug Development, 2016–2021 2023 ·The Journal of Clinical Pharmacology ·(unknown), Varsha Bhatt‐Mehta, (unknown), Gilbert J. Burckart	0
7	Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012‐2020 2021 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), Gilbert J. Burckart	12
8	Bone Mineral Density to Assess Pediatric Bone Health in Drug Development 2017 ·Therapeutic Innovation & Regulatory Science ·Brian M. Maas, Jian Wang, (unknown), (unknown), Ye Yuan, Lynne Yao, Gilbert J. Burckart	2
9	Exposure Matching of Pediatric Anti-infective Drugs: Review of Drugs Submitted to the Food and Drug Administration for Pediatric Approval 2016 ·Clinical Therapeutics ·Kanecia O. Zimmerman, (unknown), Christoph P. Hornik, P. Brian Smith, Daniel K. Benjamin, Yeruk Mulugeta, Gilbert J. Burckart, Michael Cohen‐Wolkowiez, Daniel González	5
10	Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling 2015 ·The Journal of Clinical Pharmacology ·Jian Wang, Andrea N. Edginton, Debbie Avant, Gilbert J. Burckart	16
11	Genetic polymorphisms influence mycophenolate mofetil–related adverse events in pediatric heart transplant patients 2010 ·The Journal of Heart and Lung Transplantation ·Erin Ohmann, Gilbert J. Burckart, Maria M. Brooks, (unknown), Vera Pravica, Diana M. Girnita, Adriana Zeevi, Steven A. Webber	42
12	Evaluation of Renal Drug Dosing: Prescribing Information and Clinical Pharmacist Approaches 2010 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Thomas C. Dowling, Gary R. Matzke, John E. Murphy, Gilbert J. Burckart	53
13	Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms 2003 ·American Journal of Transplantation ·Hongxia Zheng, Steven Webber, Adriana Zeevi, Erin G. Schuetz, Jiong Zhang, Pamela Bowman, Gerard Boyle, Yuk M. Law, Susan A. Miller, Jatinder K. Lamba, Gilbert J. Burckart	223
14	P‐glycoprotein (P‐gp) Is Upregulated in Peripheral T‐Cell Subsets from Solid Organ Transplant Recipients 2001 ·The Journal of Clinical Pharmacology ·(unknown), Gilbert J. Burckart, Bartley P. Griffith, Ashok Jain, Adriana Zeevi, (unknown)	33
15	Dose-Related Reversal of Acute Lung Rejection by Aerosolized Cyclosporine 1997 ·American Journal of Respiratory and Critical Care Medicine ·Aldo Iacono, Gerald C. Smaldone, Robert J. Keenan, P. Diot, James H. Dauber, Adriana Zeevi, Gilbert J. Burckart, B. Griffith	61
16	Aerosolized Cyclosporine in Lung Recipients With Refractory Chronic Rejection 1996 ·American Journal of Respiratory and Critical Care Medicine ·Aldo Iacono, Robert J. Keenan, Steve Duncan, Gerald C. Smaldone, James H. Dauber, Irvin L. Paradis, N. Paul Ohori, Wayne F. Grgurich, Gilbert J. Burckart, Adriana Zeevi, (unknown), Thomas G. O’Riordan, (unknown), Samuel A. Yousem, Bartley P. Griffith	94
17	Delivery and Distribution of Aerosolized Cyclosporine in Lung Allograft Recipients 1995 ·American Journal of Respiratory and Critical Care Medicine ·Thomas G. O’Riordan, Aldo Iacono, Robert J. Keenan, Steven R. Duncan, Gilbert J. Burckart, Bartley P. Griffith, Gerald C. Smaldone	42
18	Aspects of lung transplantation that contribute to increased severity of pneumonia 1993 ·Journal of Thoracic and Cardiovascular Surgery ·Ryo Aeba, Janet E. Stout, Nicola A Francalancia, Robert J. Keenan, Andrew Duncan, Samuel A. Yousem, Gilbert J. Burckart, Victor L. Yu, Bartley P. Griffith	10
19	Production of an Aerosol of Cyclosporine as a Prelude to Clinical Studies 1992 ·Journal of Aerosol Medicine ·Thomas G. O’Riordan, Steven R. Duncan, Gilbert J. Burckart, Bartley P. Griffith, Gerald C. Smaldone	17
20	Pharmacokinetics of Ceftriaxone in Liver‐Transplant Recipients 1991 ·The Journal of Clinical Pharmacology ·(unknown), Hisham Abdallah, (unknown), Lewis Teperman, (unknown), (unknown), Gilbert J. Burckart, Thomas E. Starzl	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact